The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results

Int J Mol Sci. 2021 Sep 21;22(18):10152. doi: 10.3390/ijms221810152.

Abstract

Cardiovascular diseases are the leading causes of death worldwide. The cardioprotective effects of natural polyphenols such as resveratrol (3,5,4-trihydroxystilbene) have been extensively investigated throughout recent decades. Many studies of RES have focused on its favorable effects on pathological conditions related to cardiovascular diseases and their risk factors. The aim of this review was to summarize the wide beneficial effects of resveratrol on the cardiovascular system, including signal transduction pathways of cell longevity, energy metabolism of cardiomyocytes or cardiac remodeling, and its anti-inflammatory and antioxidant properties. In addition, this paper discusses the significant preclinical and human clinical trials of recent years with resveratrol on cardiovascular system. Finally, we present a short overview of antiviral and anti-inflammatory properties and possible future perspectives on RES against COVID-19 in cardiovascular diseases.

Keywords: cardiovascular diseases; heart failure; inflammation; oxidative stress; resveratrol.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / pharmacology*
  • COVID-19 / pathology
  • COVID-19 Drug Treatment*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular System / drug effects*
  • Cardiovascular System / pathology
  • Humans
  • Resveratrol / pharmacology*

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Resveratrol